Cargando…

Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus

BACKGROUND: Neurodegenerative disease pathology is associated with neuroinflammation, but evidence on idiopathic normal pressure hydrocephalus (iNPH) remains limited and cerebrospinal fluid (CSF) biomarker profiles need to be elucidated. OBJECTIVE: To investigate whether iNPH pathological mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fuxia, Yang, Lu, Fang, Xuhao, Deng, Yao, Mao, Renling, Yan, Aijuan, Wei, Wenshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357212/ https://www.ncbi.nlm.nih.gov/pubmed/37182875 http://dx.doi.org/10.3233/JAD-221180

Ejemplares similares

Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus
por: Leinonen, Ville, et al.
Publicado: (2011)

Automatic Volumetry of the Cerebrospinal Fluid Space in Idiopathic Normal Pressure Hydrocephalus
por: Ishii, Kazunari, et al.
Publicado: (2013)

Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus
por: Hiraldo-González, Laura, et al.
Publicado: (2021)

One-year outcome of a lumboperitoneal shunt in older adults with idiopathic normal pressure hydrocephalus
por: Fang, Xuhao, et al.
Publicado: (2022)

Idiopathic Normal Pressure Hydrocephalus and Elderly Acquired Hydrocephalus: Evaluation With Cerebrospinal Fluid Flow and Ventricular Volume Parameters
por: He, Wen-Jie, et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus
por: Pyykkö, Okko T., et al.
Publicado: (2014)

Impact of Cerebrospinal Fluid Shunting for Idiopathic Normal Pressure Hydrocephalus on the Amyloid Cascade
por: Moriya, Masao, et al.
Publicado: (2015)

Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus
por: Lukkarinen, Heikki, et al.
Publicado: (2021)

Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus
por: Vanninen, Aleksi, et al.
Publicado: (2023)

Preliminary Exploration of the Sequence of Nerve Fiber Bundles Involvement for Idiopathic Normal Pressure Hydrocephalus: A Correlation Analysis Using Diffusion Tensor Imaging
por: Huang, Wenjun, et al.
Publicado: (2021)

Shunt Surgery Efficacy Is Correlated With Baseline Cerebrum Perfusion in Idiopathic Normal Pressure Hydrocephalus: A 3D Pulsed Arterial-Spin Labeling Study
por: Huang, Wenjun, et al.
Publicado: (2022)

Cerebrospinal fluid volumetric net flow rate and direction in idiopathic normal pressure hydrocephalus
por: Lindstrøm, Erika Kristina, et al.
Publicado: (2018)

The Utility of Serial Cerebrospinal Fluid Removal in Elderly Patients with Idiopathic Normal-Pressure Hydrocephalus?
por: Onder, Halil, et al.
Publicado: (2020)

The Outcomes Of Serial Cerebrospinal Fluid Removal In Elderly Patients With Idiopathic Normal Pressure Hydrocephalus
por: Isik, Ahmet Turan, et al.
Publicado: (2019)

Quantitative Gait Analysis and Cerebrospinal Fluid Tap Test for Idiopathic Normal-pressure Hydrocephalus
por: Lim, Yong-Hyun, et al.
Publicado: (2019)

Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus
por: Kawamura, Kaito, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients
por: Lukkarinen, Heikki, et al.
Publicado: (2022)

Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus
por: Tullberg, Mats, et al.
Publicado: (2008)

The value of the cerebrospinal fluid tap test for predicting shunt effectiveness in idiopathic normal pressure hydrocephalus
por: Ishikawa, Masatsune, et al.
Publicado: (2012)

Cerebrospinal fluid biomarkers in patients with idiopathic normal pressure hydrocephalus with temporary response to shunt insertion
por: Chan, Huan Wee, et al.
Publicado: (2015)

Magnetic resonance imaging biomarkers of cerebrospinal fluid tracer dynamics in idiopathic normal pressure hydrocephalus
por: Eide, Per Kristian, et al.
Publicado: (2020)

Differentiating comorbidities and predicting prognosis in idiopathic normal pressure hydrocephalus using cerebrospinal fluid biomarkers
por: Nakajima, Madoka, et al.
Publicado: (2021)

Distinct volumetric features of cerebrospinal fluid distribution in idiopathic normal-pressure hydrocephalus and Alzheimer’s disease
por: Han, Jaehwan, et al.
Publicado: (2022)

Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus
por: Oernbo, Eva Kjer, et al.
Publicado: (2022)

Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus
por: Weiner, Sophia, et al.
Publicado: (2023)

White matter hyperintensity mediating gait disorders in iNPH patients via neurofilament light chain
por: Yang, Lu, et al.
Publicado: (2023)

Predictive Value of Cerebrospinal Fluid Biomarkers for Tap Test Responsiveness in Patients With Suspected Idiopathic Normal Pressure Hydrocephalus
por: Hua, Rongrong, et al.
Publicado: (2021)

Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease
por: Tsai, Andrew, et al.
Publicado: (2014)

Two-Point Dynamic Observation of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus
por: Jingami, Naoto, et al.
Publicado: (2019)

The effects of cerebrospinal fluid tap-test on idiopathic normal pressure hydrocephalus: an inertial sensors based assessment
por: Ferrari, Alberto, et al.
Publicado: (2020)

A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias
por: Said, Harun Muayad, et al.
Publicado: (2022)

Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus
por: Jeppsson, A., et al.
Publicado: (2023)

Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: A pilot study
por: Lee, Jeong-Hyun, et al.
Publicado: (2012)

Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort
por: Nagata, Yuki, et al.
Publicado: (2018)

Evaluating the cerebrospinal fluid tap test with the Hellström iNPH scale for patients with idiopathic normal pressure hydrocephalus
por: Rydja, Johanna, et al.
Publicado: (2021)

Concordance of Alzheimer’s Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus
por: Lukkarinen, Heikki, et al.
Publicado: (2023)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

Exploring mechanisms of ventricular enlargement in idiopathic normal pressure hydrocephalus: a role of cerebrospinal fluid dynamics and motile cilia
por: Yamada, Shigeki, et al.
Publicado: (2021)

Intrathecal Contrast-Enhanced Magnetic Resonance Imaging of Cerebrospinal Fluid Dynamics and Glymphatic Enhancement in Idiopathic Normal Pressure Hydrocephalus
por: Eide, Per Kristian, et al.
Publicado: (2022)

Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis
por: Thavarajasingam, Santhosh G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vb2vq26qs23panou98nr14it7g